Immunohematology Market Size – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2034
Overview
Immunohematology Market size is projected to reach US$ 3.97 Bn at the end of the forecast period at a CAGR of 4%.
Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
Immunohematology Market Size, Share and Growth Analysis
To know about the Research Methodology:-Request Free Sample Report
Immunohematology is dealing with the study of antibodies and RBC antigens that are mainly related to blood transfusion. The basic rinciple of immunohematology is the reaction between antigens and antibodies, which either causes haemolysis of RBC agglutination. Immunohematology technique is mainly used to detect the presence of a particular antigen in the blood.
The key factor that drives the Immunohematology market growth includes an increase in investment by public and private organizations in constructing blood banks, which ultimately helps in increasing the sales of immunohematology devices. The growing incidence of blood cancer and blood-related diseases, such as sickle cell disease, is leading to an increase in the demand for blood transfusion procedures. These factors eventually drive the Global Immunohematology Market.
However, the high cost of analyzers and reagents and the lack of skilled professionals may limit the Global Immunohematology Market growth.
According to product segment, Immunohematology reagents are expected to dominate the market in the forecast period, owing to the increasing use of reagents in the blood banks for immunohematology tests, rising number of customization for reagents used during tests, and growing demand for regents due to increased use of immunohematology in diagnostic technologies.
Region-wise, North America is projected to dominate the Global Immunohematology Market in the forecast period, owing to the early introduction of highly developed techniques, the presence of a highly skilled workforce, diagnostics centers, and blood banks, and availability of advanced healthcare infrastructure.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding the Global Immunohematology Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the global gram Immunohematology market.
Immunohematology Market Recent Development
| Date | Company | Development | Impact |
|---|---|---|---|
| 16 October 2025 | Grifols | Grifols commenced manufacturing of its DG Gel cards and reagent red blood cells (RRBCs) at its expanded 73,541-square-foot facility in San Diego, California. | The expansion nearly doubles local manufacturing footprint to address surging U.S. demand for automated blood typing and pre-transfusion compatibility testing. |
| 10 December 2025 | Fondazione Telethon | Fondazione Telethon secured U.S. FDA approval for Waskyra, an ex vivo gene therapy designed to treat Wiskott-Aldrich syndrome (WAS). | The approval delivers a curative therapeutic approach for severe congenital immunohematological deficiencies by directly restoring functional WAS proteins in blood and immune cells. |
| 02 June 2026 | QuidelOrtho Corporation | QuidelOrtho entered into a strategic collaboration with the Allo Hope Foundation to advance education and early diagnostics for maternal red blood cell alloimmunization. | The initiative aims to improve screening workflows for hemolytic disease of the fetus and newborn (HDFN) to mitigate fetal risk during pregnancies. |
| 22 June 2026 | Grifols | Grifols commercially launched Evanzys IH, a modular and track-enabled automated platform, at the International Society of Blood Transfusion (ISBT) Congress. | The platform delivers end-to-end workflow automation and high-throughput processing to accelerate turnaround times for high-volume blood banks and clinical immunohematology laboratories. |
Immunohematology Market Scope: Inquire before buying
| Global Immunohematology Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | US $ 2.79 Bn. |
| Forecast Period 2026 to 2034 CAGR: | 4% | Market Size in 2034: | US $ 3.97 Bn. |
| Segments Covered: | by Product | Immunohematology Analyzer Immunohematology Reagents |
|
| by Application | Cancer Blood Typing Antibody Screening Blood-related diseases HIV Hepatitis |
||
| by End-user | Hospitals Academic and Research Institutes Diagnostics and Reference Laboratories Blood Banks |
||
Immunohematology Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Immunohematology Market Key Players
1.Bio-Rad Laboratories, Inc.
2.Immucor
3.Grifols
4.BD (Becton Dickinson)
5.Hologic, Inc.
6.Siemens Healthcare GmbH
7.ThermoFisher
8.Abbott
9.Beckman Coulter, Inc.
10.Ortho Clinical Diagnostics
11.Roche Diagnostics Corporation
12.Merck KGaA
13.Cardinal Health Inc.
14.CSL Ltd.
15.Danaher Corp.
16.MTC Invitro Diagnostics AG
17.F. Hoffmann-La Roche Ltd.
18.Antisel
Frequently Asked Questions:
1. Which region has the largest share in Global Immunohematology Market?
Ans: North America region held the highest share in 2025.
2. What is the growth rate of Global Immunohematology Market?
Ans: The Global Immunohematology Market is growing at a CAGR of 4% during forecasting period 2026-2034.
3. What is scope of the Global Immunohematology market report?
Ans: Global Immunohematology Market report helps with the PESTEL, PORTER, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Immunohematology market?
Ans: The important key players in the Global Immunohematology Market are – Bio-Rad Laboratories, Inc., Immucor, Grifols, BD (Becton Dickinson), Hologic, Inc., Siemens Healthcare GmbH, ThermoFisher, Abbott, Beckman Coulter, Inc., Ortho Clinical Diagnostics, Roche Diagnostics Corporation, Merck KGaA, Cardinal Health Inc., CSL Ltd., Danaher Corp., MTC Invitro Diagnostics AG, F. Hoffmann-La Roche Ltd., and Antisel
5. What is the study period of this market?
Ans: The Global Immunohematology Market is studied from 2020 to 2034.